3D Myocardial Mechanical Wave Measurements: Toward In Vivo 3D Myocardial Elasticity Mapping.
Sebastien Salles, Torvald Espeland, Alfonso Molares...
https://pubmed.ncbi.nlm.nih.gov/32861651/Actively Recruiting
Led by Assistance Publique - Hôpitaux de Paris · Updated on 2025-11-18
40
Participants Needed
2
Research Sites
52 weeks
Total Duration
Researchers are investigating the relationship between left ventricular LV myocardial stiffness and myocardial interstitial fibrosis in people with primary mitral regurgitation MR, a common heart valve disease that can lead to heart failure. The study aims to evaluate how 3D ultrasound measurements of mechanical wave velocity MWV in the heart muscle relate to fibrosis measured by cardiac magnetic resonance imaging CMR. Participants will undergo routine tests including 2D and 3D echocardiography with MWV imaging, CMR scans, 24-hour electrocardiogram monitoring, blood tests including brain natriuretic peptide levels, and symptom-limited exercise echocardiography with oxygen uptake measurements. This observational study involves no treatment but collects detailed imaging and clinical data to better understand myocardial stiffness and fibrosis. During the study, patients will have comprehensive heart imaging and monitoring to assess heart function and stiffness. Researchers will measure correlations between LV stiffness and myocardial fibrosis, as well as links to clinical stages of MR, LV mass, and heart strain. The primary outcome is the correlation between LV stiffness assessed by 3D MWV and fibrosis measured by CMR extracellular volume. The study starts in October 2024 and continues through November 2027.
CONDITIONS
3D Ultrasound Myocardial Mechanical Wave Measurements
N
Nadjib Hammoudi, MD, PhD
S
Sebastien Salles, PhD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Assistance Publique - Hôpitaux de Paris
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Single assessment visit
Participants undergo comprehensive assessments including 2D/3D echocardiography, cardiac MRI, 24-hour ECG monitoring, blood sampling, and symptom-limited exercise testing to evaluate heart function and structure.
1 visit (in-person)
Duration - Up to study completion
Participants are observed over time without receiving intervention to monitor heart condition progression.
Visits as per routine clinical follow-up
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Sebastien Salles, Torvald Espeland, Alfonso Molares...
https://pubmed.ncbi.nlm.nih.gov/32861651/Assistance Publique - Hôpitaux de Paris
Lead Sponsor